zopiclone: Clinical Trials

6 trials of zopiclone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Terminated 1

Follow zopiclone: new trials by email Literature Review of zopiclone trials Research Report on zopiclone

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SleepSure: A Trial to Assess the Effects of Eye Masks and Earplugs on Hospital Inpatient Sleep
Ear plugs, Eye Mask, Zopiclone - Sleep
Phase 3CompletedOxford University Hospitals NHS Trust2062016-11-252019-10-01
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea
Placebo, Zopiclone - Obstructive Sleep Apnea
Phase 3CompletedOSR Medical Inc.2642011-05-012015-07-17
A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia
Eszopiclone, Zopiclone - INSOMNIA
Phase 3CompletedEurofarma Laboratorios S.A.2632011-03-012015-07-27
An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.
GSK1755165; placebo; zopiclone - Healthy Subjects, Sleep Initiation and Maintenance Disorders
Phase 3CompletedGlaxoSmithKline912008-07-012012-06-05
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
Ramelteon, Zopiclone, Placebo - Balance
Phase 3CompletedTakeda2752005-07-012012-02-02

Conditions studied

Sleep Initiation and Maintenance Disorders (3)  ·  Anxiety Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)  ·  Sleep Apnea, Obstructive (1)

Sponsors

Eurofarma Laboratorios S.A. (1)  ·  GlaxoSmithKline (1)  ·  Hannover Medical School (1)  ·  OSR Medical Inc. (1)  ·  Oxford University Hospitals NHS Trust (1)  ·  Takeda (1)

Countries

United Kingdom (2)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)

Top investigators

Barbara Capozzolo, MSc (1)  ·  Derick T Wade, MD (1)  ·  Germaine Tanzimat, RN (1)  ·  Helge Frieling, Prof., MD (1)  ·  Kateri Champagne, MD DABSM (1)  ·  Marcel Baltzan, MDCM DABSM (1)  ·  Paul Verschelden, MD DABSM (1)

Results publications

PMID 26872077

NIH funding

2004 (1)